Read More

Singapore’s Eu Yan Sang Acquired by Neubauer Japanese Consortium For $516 Million

A Japanese consortium has completed the acquisition of Singapore-based traditional Chinese medicine company Eu Yang Sang International for S$695 million (US$516 million). The consortium of Neubauer, Mitsui & Co and Rohto Pharmaceutical acquired 86 per cent of Eu Yan Sang from Righteous Crane Holding, announced Tower Capital Asia in a press release on Tuesday June 4.
Read More